Page last updated: 2024-08-25

2-n-propylquinoline and Disease Models, Animal

2-n-propylquinoline has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bose, P; Dere, RT; Gopinath, VS; Gupta, S; Kumar Goud, PS; Launay, D; Martin, D; Moger, M; Pinjari, J; Puri, SK; Ramanathan, V; Rao, MV; Shivahare, R; Verma, A; Vishwakarma, P1
Balaraman, K; Bories, C; Cojean, S; Figadère, B; Kesavan, V; Loiseau, PM; Moussa, F; Pomel, S; Vacus, J; Vieira, NC1
Baudouin, R; Bories, C; Campos Vieira, N; Figadère, B; Fournet, A; Loiseau, PM; Séon-Méniel, B; Vacus, J1
Ferreira, ME; Fournet, A; Nakayama, H; Rojas de Arias, A; Schinini, A; Torres, S; Vera de Bilbao, N1

Other Studies

4 other study(ies) available for 2-n-propylquinoline and Disease Models, Animal

ArticleYear
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
    European journal of medicinal chemistry, 2013, Volume: 69

    Topics: Animals; Antiprotozoal Agents; Cell Line; Cricetinae; Disease Models, Animal; Drug Design; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mice; Parasitic Sensitivity Tests; Quinolines

2013
In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2015, Volume: 76

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Antiprotozoal Agents; beta-Cyclodextrins; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Female; Half-Life; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Male; Mice; Mice, Inbred BALB C; Quinolines; Rats; Rats, Sprague-Dawley; Tissue Distribution

2015
Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model.
    Parasite (Paris, France), 2011, Volume: 18, Issue:4

    Topics: Administration, Oral; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Phosphorylcholine; Quinolines

2011
Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline.
    Phytotherapy research : PTR, 2001, Volume: 15, Issue:7

    Topics: Animals; Chagas Disease; Chronic Disease; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Phytotherapy; Plant Extracts; Quinolines; Rutaceae; Trypanocidal Agents; Trypanosoma cruzi

2001